<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02358733</url>
  </required_header>
  <id_info>
    <org_study_id>CIRH-BROIMSI-2014</org_study_id>
    <secondary_id>2014-003928-50</secondary_id>
    <nct_id>NCT02358733</nct_id>
  </id_info>
  <brief_title>Use of IMSI in Poor Responders to IVF</brief_title>
  <official_title>Use of Intra-Cytoplasmic Morphologically Selected Sperm Injection (IMSI) in Poor Responders to In Vitro Fertilization (IVF): a Prospective, Double-blind, Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro de Infertilidad y Reproducción Humana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro de Infertilidad y Reproducción Humana</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study which aims to determine the role of IMSI in poor responders.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a pilot study which aims to determine the role of IMSI over ICSI in poor responders
      to IVF, without a background of teratozoospermia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>Four to six weeks after embryo transfer</time_frame>
    <description>Percentage of patients presenting with presence of an intrauterine gestational sac with embryonic cardiac activity display, evaluated by ultrasound, per cycle initiated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of embryos obtained</measure>
    <time_frame>Two days after egg retrieval</time_frame>
    <description>Total number of embryos obtained</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of cycles with embryo transfer</measure>
    <time_frame>Two days after egg retrieval</time_frame>
    <description>Number of cycles reaching embryo transfer per cycle initiated</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Female Infertility</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intra-cytoplasmic Morphologically-selected Sperm Injection (IMSI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intracytoplasmic sperm injection (ICSI)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intra-cytoplasmic Sperm Injection</intervention_name>
    <description>Selection of sperm at 400x for sperm injection</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intra-cytoplasmic Morphologically-selected Sperm Injection</intervention_name>
    <description>Selection of sperm at 6000x for sperm injection</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  poor ovarian response

        Exclusion Criteria:

          -  body mass index (BMI) ≥ 30 kg/m2

          -  presence of endocrinopathies (e.g., diabetes, hyperprolactinemia, hypothyroidism)

          -  altered karyotype or documented genetic defects in one or both partners

          -  history of chronic, autoimmune or metabolic diseases

          -  altered meiosis in testicular biopsy or altered sperm-FISH

          -  teratozoospermia

          -  participation, simultaneously or within the previous 6 months, in another clinical
             trial with medication
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>37 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karinna Lattes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centro de Infertilidad y Reproducción Humana (CIRH)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karinna Lattes, MD</last_name>
    <phone>+34 280 65 35</phone>
    <email>klattes@cirh.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centro de Infertilidad y Reproducción Humana (CIRH)</name>
      <address>
        <city>Barcelona</city>
        <zip>08017</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karinna Lattes, MD</last_name>
      <phone>+34 280 65 35</phone>
      <email>klattes@cirh.es</email>
    </contact>
    <investigator>
      <last_name>Karinna Lattes, MD, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Prats, BSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2015</study_first_submitted>
  <study_first_submitted_qc>February 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2015</study_first_posted>
  <last_update_submitted>May 9, 2017</last_update_submitted>
  <last_update_submitted_qc>May 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>POR</keyword>
  <keyword>IMSI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

